Results 101 to 110 of about 51,164 (250)
Abstract Purpose The present study aimed to compare the efficacy and safety of a combined injection of stromal vascular fraction (SVF) and platelet rich plasma (PRP) versus a high molecular weight (HMW) hyaluronic acid (HA) injection in patients with knee osteoarthritis (KOA).
Trifon Totlis +6 more
wiley +1 more source
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation. [PDF]
Choi MC +5 more
europepmc +1 more source
ABSTRACT Introduction/Aims Tofersen is a gene‐targeted therapy for individuals with superoxide dismutase 1 (SOD1) (+) amyotrophic lateral sclerosis (ALS). Prior to U.S. Food and Drug Administration (FDA) approval, tofersen was made available through expanded access protocol.
Alison Wheeler +30 more
wiley +1 more source
Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study. [PDF]
Cairat M +5 more
europepmc +1 more source
Abstract Background This study aimed to develop and assess a bedside nasojejunal tube placement technique designed for resource‐limited settings to address the specific challenges of enteral nutrition (EN) delivery in neurocritical care patients, particularly those at high risk of reflux and aspiration. The technique sought to overcome the drawbacks of
Niuchenglin +5 more
wiley +1 more source
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj
The impact of platelets and antiplatelets medications on immune mediation
Objective: To investigate the mechanisms through which platelets and antiplatelet therapies modulate the immune response and propose directions for future research in this field, with a particular emphasis on their impact on treatment efficacy and ...
Leela Morena, MD +11 more
doaj +1 more source
Time of Resumption of Antiplatelet Drugs After Upper Gastrointestinal Hemorrhage. [PDF]
Ma H +5 more
europepmc +1 more source
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source

